Peptide COA and Third-Party Testing: A Provider's Reading Guide

Short answer: A peptide COA (certificate of analysis) is the lot-specific quality report for a peptide material. For practices and compounders, a usable COA names the product and lot, reports identity (usually mass spectrometry), purity (usually HPLC), and peptide content, and is signed by a responsible quality person. Federal compounding law requires bulk drug substances used under section 503A to be accompanied by a valid certificate of analysis and to come from an FDA-registered establishment (21 U.S.C. § 353a; FDA). Third-party testing means an independent laboratory—not only the seller's in-house sheet—ran some or all of those assays on that lot.

This guide helps purchasing and clinical leads read a peptide COA and interpret "third party tested peptides" claims when vetting a supplier. It is not a product-quality ranking of vendors.

Why the peptide COA matters

FDA tells compounders to know their bulks suppliers and to know what testing those suppliers perform (FDA). The statute's 503A bulk conditions explicitly call for a valid COA (21 U.S.C. § 353a(b)(1)(A)). For a clinic buying lyophilized peptides, the COA is the primary document that ties the vial in your fridge to analytical results.

Compounded drugs are not FDA-approved; FDA does not review them for safety, effectiveness, or quality before marketing (FDA). Documentation is how your team does its own diligence.

What a usable peptide COA includes

Look for these fields on every lot:

1. Product identity and lot number

Name (and sequence or structure when available), strength or pack size, and a lot / batch number that matches the label on the vial. A COA without a lot number—or with a lot that doesn't match the vial—is not usable for peptide COA lookup against inventory.

2. Identity testing (usually MS)

Mass spectrometry confirms that the observed molecular weight matches the expected peptide. Manufacturer QC guidance treats MS molecular-weight determination as a standard identity check (Bachem).

3. Purity (usually HPLC)

Analytical HPLC with UV detection (commonly 210–220 nm) reports the main peak's share of total detected peak area (Bachem). Ask for the method and, when needed, the chromatogram.

4. Peptide content (assay)

Purity ≠ peptide content. Lyophilized material also holds counter-ions and residual moisture. Net peptide content is the peptide fraction relative to non-peptidic material and is often estimated from elemental nitrogen analysis (Bachem). Both purity and content matter when staff prepare solutions from a vial.

5. Appearance, water, and counter-ions

Appearance of the cake or powder, water content, and acetate (or other counter-ion) content when reported.

6. Methods, specs, dates, and signature

Named methods, acceptance criteria, test dates, laboratory identification, and a signature or electronic release from quality assurance.

7. Endotoxin / sterility when the use case calls for it

For materials intended for injection after reconstitution, ask for bacterial endotoxin results (USP Chapter <85> methods are the usual reference) and sterility results for the finished lot (FDA).

Peptide COA lookup: a quick clinic workflow

1. Pull the vial lot number from the label.
2. Request the COA for that exact lot from the supplier portal or quality contact.
3. Confirm name, sequence/MW expectation, and lot match.
4. Check identity (MS), purity (HPLC), and peptide content against the supplier's stated specs.
5. File the COA with the receiving record so nursing and the medical director can retrieve it later.

If a supplier cannot produce a lot-matched COA before or with shipment, treat that as a sourcing problem—not a paperwork inconvenience. See our peptide wholesale suppliers checklist.

What "third party tested peptides" means

Third-party testing for peptides means an independent, ideally accredited, laboratory performed identity, purity, content, and/or microbiological assays on the lot—separate from (or in addition to) the manufacturer's release testing.

When a supplier says products are third-party tested, ask:

• Which lab? Name and accreditation (for example, ISO/IEC 17025) if claimed
• Which tests? MS, HPLC, peptide content, endotoxin, sterility, residual solvents, heavy metals
• Which lot? Results must map to the lot you received
• Can we see the raw report? Not only a marketing badge

"Third party tested" without a lab name, lot number, or report is a claim, not evidence. Conversely, a clear manufacturer COA plus an independent confirmatory report is stronger documentation than either alone. FDA's advice remains the same either way: know who tested the component and what they found (FDA).

Red flags on peptide COAs

• Generic PDFs with no lot number
• Identical numbers reused across many lots
• Missing methods or specifications
• Identity mass that doesn't match the published peptide
• Refusal to share COAs until after payment with no sample docs
• "Third party tested" badges with no report attached

How Biomed Peptides handles documentation for providers

Approved provider accounts can request lot documentation as part of normal purchasing. Apply for provider access to review quality paperwork with the lyophilized catalog, or start with the broader supplier-vetting guide at peptide wholesale suppliers.

FAQ

What is a peptide COA?

A peptide COA is a lot-specific certificate of analysis reporting identity, purity, peptide content, and related quality results for that batch.

How do I do a peptide COA lookup?

Match the vial's lot number to the COA lot number, then verify identity (MS), purity (HPLC), content, and release signature against the supplier's specifications.

What does third-party testing for peptides mean?

An independent laboratory—not only the seller—performed analytical tests on the lot. Ask for the lab name, test panel, lot number, and full report.

Is HPLC purity the same as peptide content?

No. HPLC purity describes the main peak among peptide-related peaks. Peptide content describes how much of the weighed material is peptide versus salts and moisture.

What should a practice request before ordering?

A sample lot-specific COA, endotoxin/sterility reports when relevant, storage/expiration labeling, and confirmation that documentation will ship with or before each lot.

Sources

• 21 U.S.C. § 353a. Pharmacy compounding. https://www.law.cornell.edu/uscode/text/21/353a
• FDA. FDA to Compounders: Know Your Bulks and Excipients Suppliers. https://www.fda.gov/drugs/human-drug-compounding/fda-compounders-know-your-bulks-and-excipients-suppliers
• FDA. Compounding and the FDA: Questions and Answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• FDA. Pyrogen and Endotoxins Testing: Questions and Answers. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/pyrogen-and-endotoxins-testing-questions-and-answers
• Bachem. Quality Control of Amino Acids & Peptides: A Guide. https://www.bachem.com/knowledge-center/quality-control-of-amino-acids-peptides-a-guide/